News ArchivesRead News

Your Weekly Parkinson's News Update for the Week of 3.30.20

Monday March 30, 2020
Peripheral Blood Immune Cells in Parkinson's
News-Medical Lifesciences
A study led by researchers from the Department of Biomedicine at Aarhus University, Denmark, suggests it may be possible to slow down neurodegeneration by intervening at the level of the immune system. The goal would be to help immune systems correct the regulation of its cells; further studies may set the ground for a drug to do that very task.
"Scientists believe that the results of this study will also influence the development of new preventative measures. For example, it is suggested that those who are considered to be at a greater risk of developing Parkinson’s, such as those with REM sleep behavior disorder (RBD), could be monitored by screening their blood for immune cells."
Study Finds Inflammatory, Senescence Markers May Predict Progression of Parkinson's
American Journal of Managed Care
"Scientists still have a long way to go to fully understand the complex pathology of Parkinson's, but a new study lends credence to the idea that inflammatory and senescence markers could be meaningful data points to help clinicians predict the progression of the disease.
A team of investigators from British and Irish universities wanted to find out whether markers of senescence, such as telomere length and the cyclin-dependent kinase inhibitors p16 and p21, might be predictive of cognitive and motor progression among newly diagnosed people with Parkinson's."
WHO Honors Katharina Lex for Researching
Palliative Care for People with Parkinson’s
World Health Organization
"I do not give up easily – that is a useful quality to have in academic research, as the path can be rocky and strewn with setbacks,” says PhD student and nurse researcher Katharina Lex from the Institute of Nursing Science and Practice at the Paracelsus Medical University in Salzburg, Austria.
Since 2016, the Institute has been a WHO Collaborating Centre for Nursing Research and Education, working towards strengthening palliative care education and training with a focus on nurse-led palliative care services."
Charity Seeks out Non-Drug Approaches to Treat Parkinson’s
News-Medical Lifesciences
Parkinson’s UK is launching a new funding program to support innovative studies into non-drug treatments for Parkinson’s. This approach builds on Parkinson’s UK’s existing investment in many different non-pharmaceutical based therapies, including exercise, mindfulness, cognitive behavioral therapy, massage and reflexology.
Researchers are encouraged to contact Parkinson’s UK’s research team at researchapplications@parkinsons.org.uk to apply. The duration of a non-drug approaches grant is for a maximum of two years.